Parecoxib as an adjunct therapy for the treatment of refractory non-surgical cancer pain.

MLA

Thakerar, Arti, et al. “Parecoxib as an Adjunct Therapy for the Treatment of Refractory Non-Surgical Cancer Pain.” Journal of Oncology Pharmacy Practice, vol. 26, no. 6, Sept. 2020, pp. 1407–14. EBSCOhost, https://doi.org/10.1177/1078155219897744.

APA

Thakerar, A., Dines-Muntaner, S., Trifunovich, T., Alexander, M., & Fullerton, S. (2020). Parecoxib as an adjunct therapy for the treatment of refractory non-surgical cancer pain. Journal of Oncology Pharmacy Practice, 26(6), 1407–1414. https://doi.org/10.1177/1078155219897744

Chicago

Thakerar, Arti, Seamus Dines-Muntaner, Tijana Trifunovich, Marliese Alexander, and Sonia Fullerton. 2020. “Parecoxib as an Adjunct Therapy for the Treatment of Refractory Non-Surgical Cancer Pain.” Journal of Oncology Pharmacy Practice 26 (6): 1407–14. doi:10.1177/1078155219897744.